Article Text

Download PDFPDF
Pulmonary exacerbations as indicators of progression of lung disease in young children with CF

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Both authors were involved in drafting and reviewing the manuscript for important intellectual content.

  • Competing interests CHG receives funding from the US Cystic Fibrosis Foundation, the NIH (R01HL103965, R01 AI101307, P30 DK089507) and the FDA (R01 FD003704). CHG has participated on advisory board and received an unrestricted grant from Transave Inc; participated on an advisory board for KaloBios Pharm; and received an unrestricted grant from Vertex Pharmaceuticals to perform secondary data analyses. DBS has received funding from the US Cystic Fibrosis Foundation and the NIH.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Cystic fibrosis
    Catherine Ann Byrnes Suzanna Vidmar Joyce L Cheney John B Carlin David S Armstrong Peter J Cooper Keith Grimwood Marj Moodie Colin F Robertson Margaret Rosenfeld Harm A Tiddens Claire E Wainwright for the ACFBAL Study Investigators Claire E Wainwright Keith Grimwood Joyce Cheney Paul W Francis Carolyn Dakin Narelle George John B Carlin Suzanna Vidmar Colin F Robertson Rosemary Carzino Marj Moodie Robert Carter Anita Lal David S Armstrong Peter J Cooper Karen McKay A (James) Martin Bruce Whitehead Catherine A Byrnes Merrin Harger Jan Tate Harm A Tiddens Karla Graniel Krista Gerbrands Lauren Mott
  • Airwaves
    Andrew Bush Ian Pavord